At the same time, the Lp(a) level was suppressed by monoclonal antibodies to PCSK9; this suggests that PCSK9 and Lp(a) are related to MI, and PCSK9 inhibition could be the treatment option for acute MI [64]. Here, PCSK9 is linked to myocardial infarction.